Novartis India Limited

NSE:NOVARTIND.NS

674 (INR) • At close October 25, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q2
Revenue 838.8930871922.9811.7845.4787.6906665801.71,015.21,209.2860.2989.61,044.8981.1835.5937.7958.3924.66681,174.61,177.81,093.1700.41,356.21,065.81,3811,253.21,5611,676.51,148.11,4551,643.81,750.61,713.11,672.71,922.72,240.32,228.92,076.42,2222,347.92,087.52,005.72,235.32,139.22,2312,128.52,3382,374.32,195.42,028.62,223.22,189.8
Cost of Revenue 493504.6549.3539.1621.4454.9447.2527.4489.9471.5510.3574.5527.4437.5450.6399.2354.3421.4367.2353.4272.4472.6594.2514.4351.4574.6497.7597.4570.8637.7714.1532.5712.5708.1825.7814.9731.2884.4930.3950.7710.8950.6983.2884.58181,055.41,040.91,005.3876.5961.61,018.3860.1801.5826.5775.7
Gross Profit 345.8425.4321.7383.8190.3390.5340.4378.6175.1330.2504.9634.7332.8552.1594.2581.9481.2516.3591.1571.2395.6702583.6578.7349781.6568.1783.6682.4923.3962.4615.6742.5935.7924.9898.2941.51,038.31,3101,278.21,365.61,271.41,364.71,2031,187.71,179.91,098.31,225.71,2521,376.41,3561,335.31,227.11,396.71,414.1
Gross Profit Ratio 0.4120.4570.3690.4160.2340.4620.4320.4180.2630.4120.4970.5250.3870.5580.5690.5930.5760.5510.6170.6180.5920.5980.4960.5290.4980.5760.5330.5670.5450.5910.5740.5360.510.5690.5280.5240.5630.540.5850.5730.6580.5720.5810.5760.5920.5280.5130.5490.5880.5890.5710.6080.6050.6280.646
Reseach & Development Expenses 0000000000000000000000000000000000000000000000002.2000000
General & Administrative Expenses 000060.200086.7000152.4000244.5000266000338.9000497.8000482.5000000000000000103.3000000
Selling & Marketing Expenses 000019.40006100074.600098000137.5000175.1000262.2000291000000000000000906.8000000
SG&A 29.70147.955.379.6129.8117.6143.6147.7163.9226.6225.1227226.5251.7222.2342.5293.2252.1299.3403.5304.6271.7302.5514269.2311.1385.7760389.1355.1332.2773.5371.5341.5327.8559.9430.8501.1514.1142.3567.9478483186.6406.6412.84592,698.8398.700000
Other Expenses 0174.50-88.7104.2219.6168.8124.7-410.283.668.6265.2-12560.463.864.6-122.982.65669.6-280.173100.1108.9-648.2114.7310.8222.81,096144.5251226.8148.10191.5212.20000000000000000000
Operating Expenses 29.7174.5147.945.579.6193.7177.822188.4265.1354328.2272.3514550.1532.6355.2575.9520559.9300.9644.5642.9662.9119.5656.1750.5825.2907.8810.5809.5743.7814.9723.2777.4812.81,261247.4-87.21,073.91,870.61,226.51,150994.51,743.4963.6959.11,002.81,7639557721,150.31,223.3835.5762.3
Operating Income 316.1250.9173.8234.2110.7195.1162.6157.672.463.4149.430543.138.144.149.3246.223127.180.9154.4130.440.824.7323.8240.2128.4181.2870.6257.3403.998.775.5212.5339297.6-319.5790.91,397.2204.3450.544.9214.7208.5-555.7216.3139.2222.9-511421.4584-27479.2561.2651.8
Operating Income Ratio 0.3770.270.20.2540.1360.2310.2060.1740.1090.0790.1470.2520.050.0390.0420.050.2950.0250.1330.0870.2310.1110.0350.0230.4620.1770.120.1310.6950.1650.2410.0860.0520.1290.1940.174-0.1910.4110.6240.0920.2170.020.0910.1-0.2770.0970.0650.1-0.240.180.246-0.0120.2360.2520.298
Total Other Income Expenses Net 22.8102101.7102.6102.6218161.7120.1160.77963.7260.2-356.645.848.849.273.166.439.452.841-16.683.397.392.7114.4310.5207.51,044.6141.3-0.5226.6151.6148.3191.1-0.42,415-0.5-0.6-0.6-772-0.5-0.6-0.5878.3-0.7-0.6-0.7146.3-4.6-0.4423.2-2.2-0.6-1.8
Income Before Tax 338.9352.9275.5336.8213.3413.1324.3277.7233.1142.4213.1565.2-313.583.992.998.52196.8110.564.1135.5113.82413.1323.8239.9128.1165.9819.2254.1403.498.571.6209.9338.6297.22,095.5790.41,396.6203.7452.144.4214.1208322.6215.6138.6222.2297.6416.8583.6396.2477560.6650
Income Before Tax Ratio 0.4040.3790.3160.3650.2630.4890.4120.3070.3510.1780.210.467-0.3640.0850.0890.10.2620.0070.1150.0690.2030.0970.020.0120.4620.1770.120.120.6540.1630.2410.0860.0490.1280.1930.1731.2530.4110.6230.0910.2180.020.0910.10.1610.0960.0650.10.140.1780.2460.180.2350.2520.297
Income Tax Expense 45.998.471.579.466.5147.487.575.1-17.166.329.641.4-79.820.422.735.712213.935.320.267.736.576.25.2128.5111.234.465.9554.566.7142.228.242.579.6116.5106.5500.2206.1359.770.3-22.3973.764.983.863.3-316.983.553.5126.8190.2126.4147.8177.1218.2
Net Income 293254.5204257.4146.8265.7236.8202.6250.276.1183.5523.8-233.763.570.262.897-7.175.243.967.877.3-52.27.9195.3128.793.7100264.7187.4261.270.329.1130.3222.1190.7215.3584.31,036.9133.4519.4-11.8140.4143.1238.8152.3455.5138.7244.1290393.4269.8329.2383.5431.8
Net Income Ratio 0.3490.2740.2340.2790.1810.3140.3010.2240.3760.0950.1810.433-0.2720.0640.0670.0640.116-0.0080.0780.0470.1010.066-0.0440.0070.2790.0950.0880.0720.2110.120.1560.0610.020.0790.1270.1110.1290.3040.4630.060.25-0.0050.060.0690.1190.0680.2130.0620.1150.1240.1660.1230.1620.1720.197
EPS 11.8710.318.2710.425.9510.769.598.2110.133.087.4321.21-9.472.572.842.553.93-0.293.051.782.753.13-2.110.327.915.213.84.059.66.669.282.51.034.777.035.978.5418.2832.454.1714.84-0.374.394.483.474.7714.254.347.649.0712.318.44011.9913.51
EPS Diluted 11.8710.318.2710.425.9510.769.598.2110.133.087.4321.21-9.472.572.842.553.93-0.293.051.782.753.13-2.110.327.915.213.84.059.66.669.282.51.034.777.035.978.5418.2832.454.1714.84-0.374.394.483.474.7714.254.347.649.0712.318.44011.9913.51
EBITDA 293.275361.8282.7343.8216.3417.3337.9297.9256.9160231.8583.2-297.1126134.7143275.453.8158.1111.5189.5146.572.245.3332.9249.4134.7172.5825.6259.5409.8-12185220.5345.7305-308.4798.91,406.2212.9462.954.9223.6217.3-547.2225.7148.5232.2-500.9432591.6-19.4486.8568.8659
EBITDA Ratio 0.350.3890.3250.3730.2660.4940.4290.3290.3860.20.2280.482-0.3450.1270.1290.1460.330.0570.1650.1210.2840.1250.0610.0410.4750.1840.1260.1250.6590.1660.244-0.1050.0580.1340.1970.178-0.1840.4160.6280.0960.2230.0250.0950.104-0.2730.1010.0690.104-0.2350.1850.249-0.0090.240.2560.301